PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER

被引：0
|
作者：
Utelbayeva, A. [1 ]
Arzykulov, Z. [1 ]
Izhanov, E. [1 ]
机构：
[1] Kazakh Sci Res Inst Oncol & Radiol, Alma Ata, Kazakhstan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [31] Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer
    Kindler, HL
    Friberg, G
    Skoog, L
    Wade-Oliver, K
    Vokes, EE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 340 - 344
  • [32] Phase I/II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer
    Yamao, T
    Maruyama, M
    Shirao, K
    Matsumura, Y
    Yamada, Y
    Muro, K
    Sugano, K
    Shimada, Y
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S141 - S141
  • [33] Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
    Bazarbashi, Shouki
    Aljubran, Ali
    Alzahrani, Ahmad
    Mohieldin, Ahmed
    Soudy, Hussein
    Shoukri, Mohammed
    CANCER MEDICINE, 2015, 4 (10): : 1505 - 1513
  • [34] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
  • [35] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Kim, Se Hyun
    Shin, Sang Joon
    Kim, Sun Young
    Lee, Se Hoon
    Park, Young Suk
    Park, Se Hoon
    Lee, Kyung Hee
    Kim, Tae Won
    Hong, Yong Sang
    Ahn, Joong Bae
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 91 - 97
  • [36] Combining Capecitabine, Oxaliplatin and Gemcitabine (XELOXGEM) for Colorectal Carcinoma Patients Pretreated With Irinotecan - a Multicenter Phase I/II Trial
    Kim, S. H.
    Shin, S. J.
    Kim, S. Y.
    Lee, S. H.
    Park, Y. S.
    Lee, K. H.
    Kim, T. W.
    Hong, Y. S.
    Ahn, J. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S425 - S425
  • [37] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Se Hyun Kim
    Sang Joon Shin
    Sun Young Kim
    Se Hoon Lee
    Young Suk Park
    Se Hoon Park
    Kyung Hee Lee
    Tae Won Kim
    Yong Sang Hong
    Joong Bae Ahn
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 91 - 97
  • [38] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Kathrin Dellas
    Thomas Höhler
    Thomas Reese
    Florian Würschmidt
    Erik Engel
    Claus Rödel
    Wolfgang Wagner
    Michael Richter
    Dirk Arnold
    Jürgen Dunst
    Radiation Oncology, 8
  • [39] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Dellas, Kathrin
    Hoehler, Thomas
    Reese, Thomas
    Wuerschmidt, Florian
    Engel, Erik
    Roedel, Claus
    Wagner, Wolfgang
    Richter, Michael
    Arnold, Dirk
    Dunst, Juergen
    RADIATION ONCOLOGY, 2013, 8
  • [40] A Phase I Study of Capecitabine, Irinotecan, Celecoxib, and Radiation as Neoadjuvant Therapy of Patients With Locally Advanced Rectal Cancer
    Malik, Imtiaz
    Hussein, Farabi
    Bush, David
    Alqaisi, Munther
    Bernal, Pedro
    Byrd, Janet
    Garberoglio, Carlos
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 242 - 245
12345